tuberculosis (TB)

December 1, 2025

Timothy Sterling receives $5.7 million to study tuberculosis transmission

Using molecular and other data from both the bacterial and human sides of the equation, a multi-institutional team will develop prediction models of TB transmission.

By Paul Govern
Kelly Dooley, MD, PhD, MPH. (photo by Susan Urmy)
September 11, 2024

Kelly Dooley’s TB research receives MERIT Award from the NIH  

Researchers must continually chase funding for their work. Kelly Dooley’s prestigious award from the NIH is intended to help provide respite from that chase.

By Paul Govern
Kelly Dooley, MD, PhD, MPH. (photo by Susan Urmy)
July 23, 2024

VUMC joins $31 million project to speed new TB therapies

Sweeping data integration and clinical trial simulations are needed to help decide which targets to prioritize in researching new tuberculosis treatment regimens.

By Paul Govern
June 14, 2023

NIH grant boosts international TB research consortium

A new grant will help support Vanderbilt’s RePORT Brazil, one of an international consortium’s six regional tuberculosis research programs.

By Paul Govern
April 24, 2023

Novel drugs have potential for treating tuberculosis

Drug-resistant tuberculosis is on the rise, and novel antibacterial drugs called SPTs have potential for treating the deadly lung infection.

By Leigh MacMillan
February 23, 2023

NIH grant supports TB research network in Brazil

The National Institutes of Health has awarded a five-year, $5 million grant to Vanderbilt University Medical Center for continued support of the Brazil Regional Prospective Observational Research in Tuberculosis network, or RePORT-Brazil.

By Paul Govern
December 15, 2022

Dooley honored by Treatment Action Group

Vanderbilt's Kelly Dooley, MD, PhD, MPH, recently received the Research in Action Award from the Treatment Action Group (TAG).
By Paul Govern
September 29, 2022

VUMC lands grant to build top-line biosafety facility

Vanderbilt University Medical Center is set to construct a state-of-the-art BioSafety Level 3 (BSL3) facility for research involving the COVID-19 virus, anthrax and other dangerous microorganisms.
By Bill Snyder
March 30, 2022

New Clinician Spotlight: Rebecca (Ribka) Berhanu

Rebecca Berhanu, MD, assistant professor of Medicine, has joined Vanderbilt's Division of Infectious Diseases as a clinician and researcher.
By VUMC News and Communications
June 11, 2018

Confronting TB resistance

Vanderbilt researchers describe how certain tuberculosis treatments work and suggest these medications may overcome the threat of drug-resistant tuberculosis.
By Niyati Vachharajani
November 10, 2016

Grants enhance Tuberculosis Center’s global research efforts

Since July, investigators in the Vanderbilt Tuberculosis Center have been awarded research grants totaling $5 million.
By Paul Govern
August 4, 2016

HIV treatment and TB risk

Tuberculosis (TB) remains an important public health problem, particularly among people infected with the human immunodeficiency virus (HIV).
By Bill Snyder
March 17, 2016

Study explores gene’s role in protecting HIV patients from TB

An international research team led by scientists from Vanderbilt University Medical Center has identified a genetic variant that protects people with HIV from developing active tuberculosis. The variant is near the gene encoding the infection-fighting cytokine IL-12.
By Bill Snyder
1 2